首页/数据集/Additional file 1 of Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer

Additional file 1 of Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer

NIAID Data Ecosystem2026-05-02 收录

癌预后标志物

免疫疗法响应预测

数据链接：

https://figshare.com/articles/dataset/Additional_file_1_of_Novel_protein-based_prognostic_signature_linked_to_immunotherapeutic_efficiency_in_ovarian_cancer/27129324 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Material 1

应用场景：

创建时间：

2024-09-28

癌预后标志物

DNA拷贝数变异

Lung squamous cell carcinoma (LUSC) has a poor clinical prognosis and a lack of available targeted therapies. Therefore, there is an urgent need to identify novel prognostic markers and therapeutic ta

NIAID Data Ecosystem40

DataSheet_6_Cuproptosis in ccRCC: key player in therapeutic and prognostic targets.zip

癌症预后生物标志物

免疫疗法响应预测

BackgroundClassical biomarkers have been used to classify clear cell renal cell carcinoma (ccRCC) patients in a variety of ways, and emerging evidences have indicated that cuproptosis is closely relat

NIAID Data Ecosystem00

Table 2 from Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1–Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study

肿瘤免疫微环境

免疫疗法响应预测

Summary of responses (RES).

NIAID Data Ecosystem00

Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma

癌预后标志物

SIRT3基因表达分析

SIRT3, a mitochondrial sirtuin belonging to nicotinamide adenine nucleotide (NAD) dependent deacetylases, is implicated in metabolism, longevity and carcinogenesis. SIRT3 expression and its significan

Figshare2016-01-19 更新30

DataSheet_1_Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy.pdf

癌症预后生物标志物

免疫疗法响应预测

Increased mitotic activity is associated with the genesis and aggressiveness of many cancers. To assess the clinical value of mitotic activity as prognostic biomarker, we performed a pan-cancer study

NIAID Data Ecosystem00

Additional file 1 of Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer

资源简介：

相关数据集